• 2023
  Brault A, Tran-Kiem C, Couteaux C, Olié V, Paireau J, Yazdanpanah Y, Ghosn J, Martin-Blondel G, Bosetti P, Cauchemez S, , Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna., Lancet Reg Health West Pac 2023 Jan; 30(): 100634.
• 2022
  Paireau J, Mailles A, Eisenhauer C, de Laval F, Delon F, Bosetti P, Salje H, Pontiès V, Cauchemez S, , Early chains of transmission of COVID-19 in France, January to March 2020., Euro Surveill 2022 02; 27(6): .
• 2022
  Bosetti P, Tran Kiem C, Andronico A, Colizza V, Yazdanpanah Y, Fontanet A, Benamouzig D, Cauchemez S, , Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France., BMC Med 2022 01; 20(1): 33.
• 2022
  Bosetti P, Tran Kiem C, Andronico A, Paireau J, Levy-Bruhl D, Alter L, Fontanet A, Cauchemez S, , Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22., Euro Surveill 2022 01; 27(1): .
• 2021
  Bosetti P, Huynh BT, Abdou AY, Sanchez M, Eisenhauer C, Courtejoie N, Accardo J, Salje H, Guillemot D, Moslonka-Lefebvre M, Boëlle PY, Béraud G, Cauchemez S, Opatowski L, , Lockdown impact on age-specific contact patterns and behaviours, France, April 2020., Euro Surveill 2021 12; 26(48): .
• 2021
  Tran Kiem C, Bosetti P, Paireau J, Crépey P, Salje H, Lefrancq N, Fontanet A, Benamouzig D, Boëlle PY, Desenclos JC, Opatowski L, Cauchemez S, , SARS-CoV-2 transmission across age groups in France and implications for control., Nat Commun 2021 11; 12(1): 6895.
• 2021
  Tran Kiem C, Massonnaud CR, Levy-Bruhl D, Poletto C, Colizza V, Bosetti P, Fontanet A, Gabet A, Olié V, Zanetti L, Boëlle PY, Crépey P, Cauchemez S, , A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures., EClinicalMedicine 2021 Aug; 38(): 101001.
• 2021
  Tran Kiem C, Andronico A, Bosetti P, Paireau J, Alter L, Boëlle PY, Fontanet A, Lévy-Bruhl D, Cauchemez S, , Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021., Euro Surveill 2021 07; 26(26): .
• 2021
  Tran Kiem C, Crépey P, Bosetti P, Levy Bruhl D, Yazdanpanah Y, Salje H, Boëlle PY, Cauchemez S, , Lockdown as a last resort option in case of COVID-19 epidemic rebound: a modelling study., Euro Surveill 2021 06; 26(22): .
• 2021
  Andronico A, Tran Kiem C, Paireau J, Succo T, Bosetti P, Lefrancq N, Nacher M, Djossou F, Sanna A, Flamand C, Salje H, Rousseau C, Cauchemez S, , Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana., Nat Commun 2021 03; 12(1): 1634.
• 2021
  Paolo Bosetti, Bich-Tram Huynh, Armiya Youssouf Abdou, Marie Sanchez, Catherine Eisenhauer, Noémie Courtejoie, Jérôme Accardo, Henrik Salje, Didier Guillemot, Mathieu Moslonka-Lefebvre, Pierre-Yves Boëlle, Guillaume Béraud, Simon Cauchemez, Lulla Opatowski, Lockdown impact on age-specific contact patterns and behaviours in France (accepted), Eurosurveillance.
• 2021
  Bosetti P, Kiem CT, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S, , Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France., Euro Surveill 2021 01; 26(1): .